Overcoming challenges associated with identifying FBN1 deep intronic variants through whole‐genome sequencing
Journal of Clinical Laboratory Analysis · 2024
DOI: 10.1002/jcla.25009 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Laboratory Analysis, 2024. Verfasst von Jee Ah Kim und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. Hauptthemen laut MEDLINE: Marfan Syndrome, Aortic Dissection, Aortic Diseases. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Samsung Medical Center.
Abstract (Originalsprache)
Background
Marfan syndrome (MFS), caused by pathogenic variants of FBN1 (fibrillin‐1), is a systemic connective tissue disorder with variable phenotypes and treatment responsiveness depending on the variant. However, a significant number of individuals with MFS remain genetically unexplained. In this study, we report novel pathogenic intronic variants in FBN1 in two unrelated families with MFS.
Methods
We evaluated subjects with suspected MFS from two unrelated families using Sanger sequencing or multiplex ligation‐dependent probe amplification of FBN1 and/or panel‐based next‐generation sequencing. As no pathogenic variants were identified, whole‐genome sequencing was performed. Identified variants were analyzed by reverse transcription‐PCR and targeted sequencing of FBN1 mRNA harvested from peripheral blood or skin fibroblasts obtained from affected probands.
Results
We found causative deep intronic variants, c.6163+1484A>T and c.5788+36C>A, in FBN1 . The splicing analysis revealed an insertion of in‐frame or out‐of‐frame intronic sequences of the FBN1 transcript predicted to alter function of calcium‐binding epidermal growth factor protein domain. Family members carrying c.6163+1484A>T had high systemic scores including prominent skeletal features and aortic dissection with lesser aortic dilatation. Family members carrying c.5788+36C>A had more severe aortic root dilatation without aortic dissection. Both families had ectopia lentis.
Conclusion
Variable penetrance of the phenotype and negative genetic testing in MFS families should raise the possibility of deep intronic FBN1 variants and the need for additional molecular studies. This study expands the mutation spectrum of FBN1 and points out the importance of intronic sequence analysis and the need for integrative functional studies in MFS diagnosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
- Division of Cardiology, Department of Medicine, Heart Vascular Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
- Division of Cardiology, Department of Medicine, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon-si, Korea.
ORCID-Profile: Jee Ah Kim, Mi-Ae Jang, Shin Yi Jang, Duk-Kyung Kim, Young-Gon Kim, Jong-Won Kim, Taek Kyu Park, Ja-Hyun Jang
Förderung
- Samsung Medical Center
Zitieren
APA
Kim, J. A., Jang, M. A., Jang, S. Y., Kim, D. K., Kim, Y. G., Kim, J. W., Park, T. K., & Jang, J. H. (2024). Overcoming challenges associated with identifying FBN1 deep intronic variants through whole‐genome sequencing. Journal of Clinical Laboratory Analysis. https://doi.org/10.1002/jcla.25009
Vancouver
Kim JA, Jang MA, Jang SY, Kim DK, Kim YG, Kim JW, et al. Overcoming challenges associated with identifying FBN1 deep intronic variants through whole‐genome sequencing. Journal of Clinical Laboratory Analysis. 2024. doi:10.1002/jcla.25009
BibTeX
@article{Kim2024,
author = {Kim, Jee Ah and Jang, Mi-Ae and Jang, Shin Yi and Kim, Duk-Kyung and Kim, Young-Gon and Kim, Jong-Won and Park, Taek Kyu and Jang, Ja-Hyun},
title = {Overcoming challenges associated with identifying FBN1 deep intronic variants through whole‐genome sequencing},
journal = {Journal of Clinical Laboratory Analysis},
year = {2024},
doi = {10.1002/jcla.25009}
}
EUVIMED